Abstract
Glioblastoma Stem Cells: MAP17 as a Novel Predictive Biomarker and Therapeutic Target Associated with Quiescence and Immune Evasion
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have